Danaher (NYSE:DHR) (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.
The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics. Its portfolio includes well-known brands such as Beckman Coulter, Cepheid, Cytiva, Leica Microsystems, Molecular Devices, Pall and Sciex. Danaher also provides dental equipment and consumables through its dental businesses.
Founded in 1969 by Steven and Mitchell Rales, Danaher adopted its current name in 1984 and has expanded through a combination of internal development and acquisitions. The company serves customers in laboratories, hospitals, pharmaceutical and biotechnology companies, universities and research institutions worldwide. Danaher is led by President and Chief Executive Officer Rainer M. Blair.
